Vienna - Delayed Quote EUR
Johnson & Johnson (JNJ.VI)
135.98
-0.56
(-0.41%)
At close: April 24 at 5:32:16 PM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 15 | 15 | 19 | 21 |
| Avg. Estimate | 22.85B | 23.1B | 91.32B | 94.83B |
| Low Estimate | 22.51B | 22.91B | 90.82B | 93.02B |
| High Estimate | 23.09B | 23.24B | 91.87B | 96.6B |
| Year Ago Sales | 22.45B | 22.47B | 88.82B | 91.32B |
| Sales Growth (year/est) | 1.78% | 2.80% | 2.81% | 3.85% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| JNJ.VI | -- | -- | -- | -- |
| S&P 500 | 6.94% | 4.52% | 8.32% | 14.18% |
Upgrades & Downgrades
| Maintains | Barclays: Equal-Weight to Equal-Weight | 4/17/2025 |
| Maintains | Raymond James: Outperform to Outperform | 4/16/2025 |
| Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 4/16/2025 |
| Reiterates | RBC Capital: Outperform to Outperform | 4/16/2025 |
| Maintains | Raymond James: Outperform to Outperform | 4/14/2025 |
| Maintains | B of A Securities: Neutral to Neutral | 4/10/2025 |
Related Tickers
SNW.HM Sanofi SA
93.40
+0.33%
LLY.MX Eli Lilly and Company
16,785.00
+4.25%
LLY0.DU Eli Lilly and Co
19.60
+2.08%
GRF.MC Grifols, S.A.
8.45
+0.64%
GSK GSK plc
37.50
+1.27%
AMGN Amgen Inc.
279.84
+0.70%
BMY Bristol-Myers Squibb Company
48.69
+0.33%
ABBV AbbVie Inc.
180.37
+1.88%
PFE Pfizer Inc.
22.78
+1.74%
NVO Novo Nordisk A/S
62.63
+2.17%